Old Web
English
Sign In
Acemap
>
authorDetail
>
Sheila Gujrathi
Sheila Gujrathi
Genentech
Medicine
Immunology
Population
Placebo
Rheumatoid arthritis
3
Papers
363
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study)
2012
Annals of the Rheumatic Diseases
Jeffrey L. Kaine
Geoffrey Gladstein
Ingrid Strusberg
Manuel Robles
Ingrid Louw
Sheila Gujrathi
Ramesh Pappu
Ingrid Delaet
Miranda Pans
Charles Ludivico
Show All
Source
Cite
Save
Citations (60)
Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I/II randomized, blinded, placebo-controlled, dose-ranging study†
2008
Arthritis & Rheumatism
Mark C. Genovese
Jeffrey L. Kaine
Mitchell B. Lowenstein
José Del Giudice
Andrew R. Baldassare
Joy Schechtman
Edward J. Fudman
Michael Kohen
Sheila Gujrathi
Robert G. Trapp
Nadera J. Sweiss
Greg Spaniolo
Wolfgang Dummer
Show All
Source
Cite
Save
Citations (180)
Total serum IgE levels in a large cohort of patients with severe or difficult-to-treat asthma
2005
Annals of Allergy Asthma & Immunology
Larry Borish
Bradley E. Chipps
Yamo Deniz
Sheila Gujrathi
B. Zheng
Chantal M. Dolan
Show All
Source
Cite
Save
Citations (123)
1